The Second Chance for Moms Act would require mifepristone, a medication used in medication abortion, to carry a warning label stating that the drug's effects can allegedly be counteracted by natural progesterone and directing women to call a federal hotline for more information. The bill would also establish a federally-funded, toll-free hotline operating 24 hours a day, seven days a week, to provide information and support to women seeking to reverse mifepristone's effects. The warning label requirement would take effect six months after the bill becomes law. This legislation would affect women who take mifepristone and the federal healthcare system, though the bill does not specify funding amounts for the hotline. The bill was introduced in March 2024 and referred to the House Committee on Energy and Commerce.